Ebola

Scientists supported by the NIAID discover a set of broadly neutralizing antibodies in the blood of Ebola survivors capable of providing substantial protection against the disease.

We're discussing presentations ranging from radiation biodosimetry to rapid viral testing

There have been no confirmed cases of Ebola in the Democratic Republic of the Congo since June 6.

An Ebola virus outbreak that began in the DRC in May has been the first in which a new vaccine and several therapeutic drugs have been available, and health officials around the world are praising the response.

The FDA seeks a permanent injunction against a company selling unapproved hand sanitizers that claim to be effective against infections from several pathogens.

Single-dose vaccines delivered via a new technology platform may offer full protection against Zika, Lassa fever, and Ebola.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

A new report by Global Health Technologies Coalition assesses the economic impact of cuts to global health R&D on the economies of US states.

A recent study has found that a single-dose of Merck's Ebola vaccine delivers antibodies that can last for 1 to 2 years.

The tech mogul shares that world leaders need to prepare for the next pandemic—whatever the root cause—including plans for mobilizing military, health, and other resources while coordinating efforts with private industry.

The US Centers for Disease Control and Prevention (CDC) has requested funds for a new high containment lab; let's give it to them.

The program can detect viral hemorrhagic fevers about 12 days faster than previous efforts.

The Global Virome Project is set to launch in 2018, and will spend the next 10 years working to identify as many as 827,000 unknown viruses in the wild.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Forty years after the first Ebola outbreak in the Democratic Republic of Congo, investigators find that a small group of survivors are still producing virus-fighting antibodies.

A research team has found that an antiviral drug available in Russia and a few other countries shows promising results when it comes to fighting Ebola virus disease.

In a new study, a pair of Australian virologists argue that we cannot predict virus outbreaks, looking at the “fault lines” of interaction between humans and animals may help us be better prepared.

Although there have been important improvements to existing vaccines, the list of vaccine-preventable diseases has barely changed at all in over two decades.

Both test vaccines produced immune responses by 1 month after vaccination and the immune response lasted for at least 1 year.

News about the Zika virus dominated our top articles for the month of September 2017. Did you read them all?

In a new study reviewing existing literature, researchers have found that more than 2 dozen viruses have been detected in human semen.

Despite clearing the virus, researchers find that Ebola survivors can suffer long-term effects of infection.

In a recent updated report, the Centers for Disease Control and Prevention’s Global Disease Detection Operations Center identifies the most recent public health threats, including those that could lead to a pandemic.

Shedding light on the perils of faulty personal protective equipment.

A recent study suggests that Ebola virus RNA can remain in the genital tract for more than 2 years following the acute infection period.

Scientists make an interesting connection between bats and detecting undiscovered disease.

Ebola virus tracking and mechanisms to detect threats to our national food supply are highlighted.

The World Health Organization has officially declared that the recent Ebola outbreak in the Democratic Republic of Congo is over.

The World Bank recently announced plans to issue “pandemic bonds and derivatives” to help fund its Pandemic Emergency Finance Facility, which will “channel surge funding” to at-risk countries in the developing world.